Not everyone responds to statins, the standard treatment for people at risk of cardiovascular disease, so an alternative based on genetically engineered immune cells could help prevent arteries from becoming blocked with plaque New Scientist – Health
Not everyone responds to statins, the standard treatment for people at risk of cardiovascular disease, so an alternative based on genetically engineered immune cells could help prevent arteries from becoming blocked with plaque
